Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation

NCT02863809 is registered in ClinicalTrials.gov with Joseph B. Ciolino, MD as lead sponsor.

NCT NCT02863809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02863809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
Lead sponsor
Joseph B. Ciolino, MD
Phase
Phase 1/2
Overall status
Completed
Start date
March 15, 2017
Completion date
August 31, 2021
Enrollment
76 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

keratolysis